We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Belluscura Plc | LSE:BELL | London | Ordinary Share | GB00BD3B8Z11 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 7.75 | 7.00 | 8.50 | 7.75 | 7.75 | 7.75 | 99,055 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Surgical,med Instr,apparatus | 1.54M | -8.15M | -0.0593 | -1.31 | 10.66M |
From Apr 2022 to Apr 2024
TIDMBELL
RNS Number : 4671O
Belluscura PLC
31 January 2023
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK version of the Market Abuse Regulation (EU) No.596/2014, which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018 ("UK MAR").
Belluscura plc
("Belluscura", the "Company" or the "Group")
Posting of Circular
Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, confirms that further to its announcement on 27 January 2023, a circular ("the Circular") and Notice of General Meeting has today been posted to shareholders.
General Meeting
The General Meeting will take place at 11.00 on 16 February 2023 at 15 Fetter Lane, London EC1A 4JN.
A copy of the Circular is available from the Company's website : wwww.belluscura.com
For further information please contact:
Belluscura plc Tel: +44 (0)20 3128 8100 Adam Reynolds, Chairman Robert Rauker, Chief Executive Officer Anthony Dyer, Chief Financial Officer SPARK Advisory Partners Limited Tel: +44 (0)20 3368 3550 Nominated Adviser Neil Baldwin Dowgate Capital Limited Tel: +44 (0)20 3903 7715 Broker and Bookrunner James Serjeant / Russell Cook MHP Tel: +44 (0)20 3128 8100 Financial PR & Investor Relations Katie Hunt/Peter Lambie/ Matthew Taylor email: Belluscura@mhpgroup.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
CIRFLFVELAILVIV
(END) Dow Jones Newswires
January 31, 2023 10:41 ET (15:41 GMT)
1 Year Belluscura Chart |
1 Month Belluscura Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
